Eric Schoen
CIK 1532303 · Chief Financial Officer · last filed 2025-04-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
22
Lifetime Open-Market Net
-$48.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CASSAVA SCIENCES INC (SAVA) Delisted | Chief Financial Officer | 11,500 | $2.34 | $27.0K | -$83.6K | 9 | 2025-04-21 |
| CASSAVA SCIENCES INC (SAVAW) Delisted | Chief Financial Officer | 23,300 | $0.03 | $699 | $0 | 1 | 2024-04-17 |
| CASSAVA SCIENCES INC (PTIE) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2018-11-01 |
| Aspira Women's Health Inc. (VRML) Delisted | SVP Finance & CAO | 29,872 | — | — | $34.8K | 9 | 2017-03-27 |
Recent Filings · Page 2 of 3
22 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-19 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +5,300 | $10.0K | EDGAR |
| 2019-05-15 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +10,000 | $10.6K | EDGAR |
| 2018-11-01 | CASSAVA SCIENCES INC (PTIE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-27 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-15 | Aspira Women's Health Inc. (VRML) Delisted | Buy (P) | +3,347 | $4.7K | EDGAR |
| 2016-06-20 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-08 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-20 | Aspira Women's Health Inc. (VRML) Delisted | Buy (P) | +5,000 | $7.1K | EDGAR |
| 2014-03-31 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-16 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.